The Limited Times

Now you can see non-English news...

Hopp speaks power: sale of vaccine manufacturer to Elon Musk - "pure fantasy"

2020-09-02T20:12:39.174Z


Tesla boss Elon Musk's flying visit to vaccine manufacturer Curevac sparked wild speculation about takeover. Curevac main owner Dietmar Hopp makes a clear announcement.


Tesla boss Elon Musk's flying visit to vaccine manufacturer Curevac sparked wild speculation about takeover.

Curevac main owner Dietmar Hopp makes a clear announcement.

  • Tesla

    boss

    Elon Musk

    is on tour in Germany.

  • His visit to the vaccine manufacturer

    Curevac sparked

    speculation about a possible takeover offer.

  • Curevac main owner

    Dietmar Hop

    p speaks a word of power to Merkur.de.

Munich - The main owner of the vaccine

manufacturer Curevac

,

Dietmar Hopp

, has

commented

positively on a possible collaboration between the Tübingen company and

Elon

Musk

.

"For Curevac, I can say that you see a great deal of potential in the collaboration with Mr. Musk and that a collaboration that goes far beyond vaccines is judged extremely positively," Hopp told Merkur.de on Tuesday.

Speculations about the US entrepreneur's possible entry into

Curevac

,

on the other hand, were decidedly rejected by

the co-founder of the software giant

SAP

.

Corresponding considerations are "pure fantasy".

Curevac

has only been on the stock exchange for three weeks, "with great success so far" and "well financed".

In addition, "my promise that Curevac is and will remain a German company" still applies, "Hopp told Merkur.de.

Hopp

holds

around 49 percent of the Curevac shares

through its subsidiary

dievini Hopp Biotech

.

In June the federal government announced that it would acquire around 23 percent of the company through KfW for EUR 300 million.

Curevac

also

countered

speculation on Wednesday about a possible entry by Musk.

It was said that there was “no question” of this during Musk's visit on Tuesday.

It was a working visit.

The meeting was only about a long-standing cooperation between Curevac and the

Tesla

subsidiary Grohmann.

The company from Prüm in the Eifel builds portable printers on behalf of Curevac with which mRNA messenger molecules can be produced.

Similar to the Mainz biotech company

Biontech

,

Curevac

also relies on so-called mRNA technology for vaccine development.

A genetic blueprint for modified virus components is injected into the body.

Corresponding proteins are then produced in the body's own cells, which trigger the body's defense reaction.

#ElonMusk arrives at #cducsu event in Berlin.

Asked if the cameras in his car livestream to the US, Musk laughs and says: “It's not true” #tesla pic.twitter.com/jtZQZ0b99V

- Arne Delfs (@ArneDelfs) September 2, 2020

After his meeting in Tübingen, Musk traveled on to

Berlin

, where he took part in the retreat of the CDU / CSU parliamentary group on Wednesday afternoon.

According to reports, talks with Economics Minister Peter Altmaier, Health Minister Jens Spahn and Union parliamentary group leader Ralph Brinkhaus were also planned on the sidelines of the meeting.

Tesla

is building a new plant in Grünheide near Berlin.

The tapes should start running there as early as next summer.

According to its own information, the e-car pioneer wants to invest around one billion euros in the new location in Brandenburg.

Source: merkur

All news articles on 2020-09-02

Similar news:

You may like

News/Politics 2024-03-13T15:32:54.000Z
News/Politics 2024-03-13T13:44:35.090Z
News/Politics 2024-03-12T13:23:03.746Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.